A research filter, not a predictor — not financial advice. Grades rank growth stocks on evidence-based quality signals from end-of-day data; they are not buy/sell calls or price forecasts. Always do your own research.
Novanta Inc. NOVT
Weak broader-coverage candidate · Operating globally, Novanta Inc.
On FrontierLab's discovery record since 2026-07-01 (13 weeks ago) — when this name first surfaced. (distinct from the snapshot date below)
Auto-graded broader coverage — sourced by an automated screen and graded on default bands, not the sector-calibrated bands the curated screener uses. A "Weak" here is NOT the same bar as a curated grade; these are auto-screened candidates for your own research, shown as of their surface date (2026-09-18), not the curated Frontier signal.
Key quality signals
| Revenue growth (YoY) | 7.6% |
|---|---|
| Gross margin | 42.5% |
| Gross profits / assets | 0.2 |
| Rule of 40 | 18 |
| Net margin | 10.4% |
| Cash runway (months) | — |
| PEG | — |
| Price / sales | 4.6 |
Quality checklist
- ✗ Revenue growth — 7.6% (pass ≥ 20%)
- ~ Gross profits / assets — 0.2 (pass ≥ 0.33)
- ~ Gross margin — 42.5% (pass ≥ 60%)
- ✓ Cash generation
- ✗ Share dilution — 14.1%
Fundamentals — snapshot as of 2026-09-18
| Stage | Established |
|---|---|
| Share issuance (YoY) | 14.1% · heavy issuance |
| Moat | — |
| TAM | — |
| P/E (trailing) | 85.6 |
| EPS (trailing) | $1.56 |
| Burn multiple | — |
| Gross-margin trend (pts) | -1 |
| Cash / assets | 0.34 |
| Net debt / EBITDA | -3.1 |
| Statements as of | Q2 FY2026 · filed 2026-08-05 |
Momentum context — a snapshot from 2026-09-18, not current
| Price at surface | $133.55 (as of 2026-09-18) |
|---|---|
| 52-week range | $98.27 – $176.38 |
| % off 52-wk high | -24.3% |
| RSI (14) | 35 |
| Relative volume | 1.2× |
Risk flags
← All broader-coverage names · Curated names → · Open the interactive screener →
Data as of 2026-09-18 (end-of-day). How grades are computed →